Page 1 of Clinical Trials for Drug Doxorubicin hydrochloride liposomal, 265 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
Last Updated: May 18, 2011
Condition(s): Resistant Solid Malignancies
2
Terminated
Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma
Last Updated: January 24, 2012
Condition(s): Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
3
Recruiting
Carboplatin, Pegylated Liposomal Doxorubicin Hydrochloride, and Everolimus in Treating Patients With Relapsed Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Last Updated: September 20, 2011
Condition(s): Fallopian Tube Cancer; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer
4
Completed
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
Last Updated: December 28, 2011
Condition(s): Breast Cancer; Drug/Agent Toxicity by Tissue/Organ; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
5
Active, not recruiting
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer
Last Updated: June 6, 2011
Condition(s): HER2-positive Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
6
Completed
Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Last Updated: June 8, 2011
Condition(s): Multiple Myeloma; Myeloma; M-Protein; Myeloma Proteins
7
Recruiting
Carfilzomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Relapsed or Refractory Multiple Myeloma
Last Updated: October 6, 2011
Condition(s): Multiple Myeloma
8
Recruiting
A Phase 1/2 Study of Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Patients With Relapsed/Refractory Multiple Myeloma
Last Updated: February 23, 2012
Condition(s): Multiple Myeloma
9
Completed
Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma
Last Updated: June 23, 2005
Condition(s): Sarcoma, Kaposi; HIV Infections
10
Active, not recruiting
Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed MM
Last Updated: April 12, 2012
Condition(s): Multiple Myeloma
11
Recruiting
BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Ovarian Cancer (OC)
Last Updated: May 2, 2012
Condition(s): Ovarian Neoplasms; Peritoneal Neoplasms
12
Completed
Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy
Last Updated: May 16, 2011
Condition(s): Ovarian Neoplasms
13
Active, not recruiting
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
Last Updated: May 18, 2011
Condition(s): Resistant Solid Malignancies
14
Not yet recruiting
Veliparib and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer
Last Updated: August 3, 2010
Condition(s): Breast Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
15
Recruiting
Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Last Updated: October 6, 2011
Condition(s): Liver Neoplasms
16
Active, not recruiting
Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With MM
Last Updated: February 21, 2012
Condition(s): Multiple Myeloma
17
Completed
Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma.
Last Updated: June 23, 2005
Condition(s): Sarcoma, Kaposi; HIV Infections
18
Active, not recruiting
Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse
Last Updated: October 25, 2007
Condition(s): Ovarian Cancer; Fallopian Tube Cancer
19
Recruiting
A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
Last Updated: May 24, 2012
Condition(s): Neoplasm Malignant
20
Active, not recruiting
A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection in Patients With Multiple Myeloma
Last Updated: February 23, 2011
Condition(s): Multiple Myeloma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Doxorubicin+hydrochloride+liposomal

Page 1 of Clinical Trials for Drug Doxorubicin hydrochloride liposomal, 265 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About